1. Home
  2. WS vs SLNO Comparison

WS vs SLNO Comparison

Compare WS & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Worthington Steel Inc.

WS

Worthington Steel Inc.

HOLD

Current Price

$38.92

Market Cap

2.0B

Sector

N/A

ML Signal

HOLD

Logo Soleno Therapeutics Inc.

SLNO

Soleno Therapeutics Inc.

HOLD

Current Price

$53.01

Market Cap

2.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WS
SLNO
Founded
1955
1999
Country
United States
United States
Employees
4800
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
2.3B
IPO Year
2023
2014

Fundamental Metrics

Financial Performance
Metric
WS
SLNO
Price
$38.92
$53.01
Analyst Decision
Buy
Buy
Analyst Count
2
9
Target Price
$42.50
$83.00
AVG Volume (30 Days)
189.5K
1.5M
Earning Date
03-25-2026
05-08-2026
Dividend Yield
1.76%
N/A
EPS Growth
N/A
108.90
EPS
1.30
0.59
Revenue
$3,093,300,000.00
$1,450,788.00
Revenue This Year
$16.77
$150.46
Revenue Next Year
$2.69
$50.37
P/E Ratio
$29.95
$89.83
Revenue Growth
N/A
138.82
52 Week Low
$24.36
$29.43
52 Week High
$49.17
$89.12

Technical Indicators

Market Signals
Indicator
WS
SLNO
Relative Strength Index (RSI) 53.48 77.32
Support Level $38.01 $48.91
Resistance Level $39.29 $55.47
Average True Range (ATR) 1.83 0.05
MACD -0.29 -0.52
Stochastic Oscillator 41.89 100.00

Price Performance

Historical Comparison
WS
SLNO

About WS Worthington Steel Inc.

Worthington Steel Inc is a processor of carbon flat-rolled steel, a producer of laser-welded solutions, and a provider of electrical steel laminations. The company has manufacturing facilities across the United States, Canada, China, India, Germany and Mexico. It buys coils of steel from primary steel producers and processes them to precise type, thickness, length, width, shape, and surface quality required by customer specifications. The company's product lines and processing capabilities include; carbon flat-rolled steel processing, electrical steel laminations, and tailor welded products. Geographically, the company generates a majority of its revenue from the United States followed by Canada, Mexico, and other regions.

About SLNO Soleno Therapeutics Inc.

Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.

Share on Social Networks: